BCAX R&D Expenses
Bicara Therapeutics Inc · R&D Expenses
BCAX R&D Expenses
Latest reported$45.77Mperiod ending
BCAX Quarterly R&D Expenses ($6.56M → $45.77M)
Quarterly R&D Expenses
High-resolution chart · PNG
BCAX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 45,773,000 | |
| 47,500,000 | |
| 32,990,000 | |
| 5,817,000 | |
| 24,798,000 | |
| 34,333,000 | |
| 19,883,000 | |
| 15,864,000 | |
| 15,841,000 | |
| 12,032,000 | |
| 10,562,000 | |
| 6,939,000 | |
| 6,556,000 | |
| 6,556,000 |